Trial Profile
Incidence of immediate onset systemic allergic reactions in patients treated With Plenaxis [abarelix]
Status:
Suspended
Phase of Trial:
Phase IV
Latest Information Update: 15 May 2007
Price :
$35
*
At a glance
- Drugs Abarelix (Primary)
- Indications Prostate cancer
- Focus Adverse reactions
- Sponsors Praecis Pharmaceuticals
- 15 May 2007 New trial record.